Strongyloides hyperinfection: a treatment dilemma

Area of Science:

• Medical Parasitology
• Infectious Diseases
• Clinical Case Reports

Background:

• Strongyloides stercoralis is a nematode parasite causing significant gastrointestinal morbidity globally.
• Chronic infections are typical, but hyperinfection syndrome poses a severe risk, particularly in immunosuppressed patients.
• Standard treatments can be challenging in severe or disseminated Strongyloides infections.

Observation:

• A case of severe Strongyloides hyperinfection syndrome in an immunosuppressed patient is presented.
• The patient experienced overwhelming parasitic infection, indicating a critical clinical scenario.
• Conventional therapies were not detailed, but the severity suggested a need for effective intervention.

Findings:

• Successful treatment of Strongyloides hyperinfection was achieved using a veterinary formulation of parenteral ivermectin.
• Parenteral administration bypasses gastrointestinal absorption issues, potentially increasing efficacy.
• This approach offers a viable alternative for managing complex or refractory cases.

Implications:

• Veterinary parenteral ivermectin may be a valuable therapeutic option for human Strongyloides hyperinfection syndrome.
• This case highlights the potential for repurposed veterinary drugs in human medicine.
• Further research into parenteral ivermectin for severe helminthic infections is warranted.